chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vaccination site pain, Vomiting
Clinical narrative: Injection site pain; Arm pain; Tiredness; Headache; Muscle pain; Joint pain; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, and adhesive allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified medication within two weeks of vaccination. On 09Apr2021 at 17:00, the patient experienced injection site pain and arm pain, tiredness, headache, muscle pain, joint pain, nausea and vomiting, diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain and arm pain, tiredness, headache, muscle pain, joint pain, nausea and vomiting, diarrhea were resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Hypomenorrhoea, Pain assessment
Clinical narrative: Less bleeding than normal; Extreme menstrual cramping  my cramps are usually 2/10 but I experienced about 8/10 pain; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine headache, latex allergy and allergic bananas. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol/norgestimate (TRINESSA) for birth control and vitamins nos (DAILY VITAMINS) used for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 22:00, the patient had extreme menstrual cramping. The patient cramps are usually 2/10 but experienced about 8/10 pain. Went to the doctor thinking the patient was having an apendicitus, all medical tests done came back healthy. The pain began 3 days before patient took blank pill, period came at a normal time (5 days after the pain began) with less bleeding than normal on 21Apr2021. The patient was currently on the last day of cycle and the pain was still debilitating. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme menstrual cramping and less bleeding than normal were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Got a pretty strong nose bleed from both nostrils; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 16:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 24Apr2021 at 22:30 (also reported as 22:00), 30 hours after the injection, the patient got a pretty strong nose bleed from both nostrils. And then again 47 hours after injection. The event did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measure was not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pretty strong nose bleed from both nostrils was unknown at the time of this vaccination.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Tinnitus
Clinical narrative: Dose 1: 29Mar2021; dose 2: 08Apr2021; Severe tinnitus; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 17:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 17:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. On 30Mar2021 at 04:00, the patient experienced severe tinnitus. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe tinnitus was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Pain
Clinical narrative: On the morning of 4/23 around 12:30am, I began to develop flu-like symptoms; Body aches; Fever; Chills; Mild headache; I had terrible joint pain as well in my elbows, wrists, ankles, and my knees. It was most severe in my knees. They throbbed consistently.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included kawasaki's disease in 2002, latex allergy, allergy to nickel and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fluoxetine (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN); both for unknown indicatiion on unknown date and unknown if ongoing. The patient previously took cefaclor (CECLOR) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On the morning of 23Apr2021 around 00:30, the patient began to develop flu-like symptoms. The patient had body aches, fever, chills and a mild headache. The patient had terrible joint pain as well in her elbows, wrists, ankles, and her knees. It was most severe in her knees. They throbbed consistently. It hurt to stand. Her symptoms continued for about 36 hours. The patient no longer had them. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL), which somewhat alleviated her symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began to develop flu-like symptoms; had body aches, fever, chills and a mild headache; had terrible joint pain as well in her elbows, wrists, ankles, and her knees; it was most severe in her knees; they throbbed consistently; it hurt to stand. Her symptoms continued for about 36 hours was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: On the morning of 4/23 around 12:30am, I began to develop flu-like symptoms; Body aches; Fever; Chills; Mild headache; I had terrible joint pain as well in my elbows, wrists, ankles, and my knees. It was most severe in my knees. They throbbed consistently.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included kawasaki's disease in 2002, latex allergy, allergy to nickel and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fluoxetine (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN); both for unknown indicatiion on unknown date and unknown if ongoing. The patient previously took cefaclor (CECLOR) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On the morning of 23Apr2021 around 00:30, the patient began to develop flu-like symptoms. The patient had body aches, fever, chills and a mild headache. The patient had terrible joint pain as well in her elbows, wrists, ankles, and her knees. It was most severe in her knees. They throbbed consistently. It hurt to stand. Her symptoms continued for about 36 hours. The patient no longer had them. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL), which somewhat alleviated her symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began to develop flu-like symptoms; had body aches, fever, chills and a mild headache; had terrible joint pain as well in her elbows, wrists, ankles, and her knees; it was most severe in her knees; they throbbed consistently; it hurt to stand. Her symptoms continued for about 36 hours was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: The afternoon following the 2nd vaccine i broke out in hives and started itching. From the bottom of my feet to my neck. My legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night; The afternoon following the 2nd vaccine i broke out in hives and started itching. From the bottom of my feet to my neck. My legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cardiomyopathy, congestive heart failure and left bundle branch block. The patient had known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 22Mar2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously received iodine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 12Apr2021 at 15:00, the afternoon following the second vaccine, the patient experienced break out in hives and started itching. From the bottom of her feet to neck. Her legs, arms, back, stomach, hands. This went on for 4 days straight. It got worse in the evenings and at night. It slacked off for a few days and started back up. It was so unbearable that she had to go to the emergency room. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with 3 different medications which were unspecified. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the afternoon following the second vaccine the patient had break out in hives and started itching from the bottom of her feet to her neck, legs, arms, back, stomach, hands, this went on for 4 days straight and it got worse in the evenings and at night was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fatigue; Flu-like symptoms; Low grade fever; This is a spontaneous report from a contactable consumer. A 77-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on an unknown date in Mar2021 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date in Mar2021 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, the patient experienced sore arm, fatigue, flu-like symptoms, low grade fever for several days after second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events sore arm, fatigue, flu-like symptoms, low grade fever were recovered on an unknown date in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Rash
Clinical narrative: Large growing rash that is hot to touch sore and spreading; Large growing rash that is hot to touch sore and spreading; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, the patient experienced large growing rash that was hot to touch sore and spreading. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large growing rash that was hot to touch sore and spreading were not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy rash around injection site, roughly 2 sq inches in size.; Itchy rash around injection site, roughly 2 sq inches in size.; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 14Apr2021 at 11:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included norethisterone acetate, ethinylestradiol, ferrous fumarate (AUROVELA FE 1/20) taken for unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 15Mar2021 at 12:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 20Apr2021 at 01:30 the patient experienced itchy rash around injection site, roughly 2 square inches in size. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event itchy rash around injection site, roughly 2 square inches in size was not recovered at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Eye swelling, Lip swelling, Peripheral swelling, Urticaria
Clinical narrative: Broke out in hives 24 hrs later in the warms areas of body neck, behind knees, inner side of elbow, under arms, thighs, stomach and below buttocks; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; My lips, eyes, ears and feet swelled up; This is a spontaneous report from a contactable consumer (patient).    A 46-yearsold non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 17:15 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The vaccine was administered at public health facility. Medical history included sinuses. Concomitant medications included tizanidine; beta vulgaris, folic acid, malus spp. vinegar extract, punica granatum, vitamin b12 nos (GOLI); antibiotics; vitamins, all taken for an unspecified indication, start and stop date were not reported. On 21Apr2021 17:30, the patient experienced broke out in hives 24 hrs later in the warms areas of body neck, behind knees, inner side of elbow, under arms, thighs, stomach and below buttocks; my lips, eyes, ears and feet swelled up. The events required a visit to the physician's office. Therapeutic measures were taken as a result of the events included a  steroid shot plus 5 days of oral meds prednisone. The outcome of the events was recovering. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 09Jan2021 (Blood test).  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Ear swelling, Headache, Pain in extremity, SARS-CoV-2 test
Clinical narrative: My ear neck; Face got swollen; Still have severe pain on my head; Severe pain in shoulder; Still have sever pain in my arm; Still have sever pain on my leg only on right side of body; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 09:45(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included type I diabetes, high blood pressure, epilepsy, pancreatitis and known allergies to penicillin, sea shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin (MANUFACTURER UNKNOWN) and buprenorphine (BUTRANS) patches; both for an unknown indication from unknown date and unknown if ongoing. On 23Apr2021 at 08:00 the patient experienced his ear neck and face got swollen. Still have severe pain on his head, shoulder and arm and leg only on right side of body. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On 05Nov2020, the patient underwent COVID-19 test (Nasal swab) and the result was negative. The clinical outcome of the events ear neck, face got swollen, severe pain on his head, shoulder and arm and leg only on right side of body was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: My ear neck; Face got swollen; Still have severe pain on my head; Severe pain in shoulder; Still have sever pain in my arm; Still have sever pain on my leg only on right side of body; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 09:45(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included type I diabetes, high blood pressure, epilepsy, pancreatitis and known allergies to penicillin, sea shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin (MANUFACTURER UNKNOWN) and buprenorphine (BUTRANS) patches; both for an unknown indication from unknown date and unknown if ongoing. On 23Apr2021 at 08:00 the patient experienced his ear neck and face got swollen. Still have severe pain on his head, shoulder and arm and leg only on right side of body. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On 05Nov2020, the patient underwent COVID-19 test (Nasal swab) and the result was negative. The clinical outcome of the events ear neck, face got swollen, severe pain on his head, shoulder and arm and leg only on right side of body was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Pain
Clinical narrative: Headache; Mild 102 degree temp; Achy; Achy joints; Tired; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 18Apr2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and benazepril (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 11:00, the patient experienced headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; Mild 102 degree temp; Achy; Achy joints; Tired; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 18Apr2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and benazepril (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 11:00, the patient experienced headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, mild 102 degree (units unspecified) temperature, felt achy, had achy joints and felt tired was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Pain, Pain in extremity
Clinical narrative: Sore arm; Achy upper body; Feverish without fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 12:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VITAMIN D), cetirizine hydrochloride (ZYRTEC), ethinylestradiol, norethisterone acetate (JUNEL) and multivitamins (MANUFACTURER UNKNOWN), for unknown indications from unknown dates and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Mar2021 at 13:00, the patient experienced sore arm for 4 to 5 days, achy upper body, feverish without fever for 3 to 4 hours in 24 hours after first dose and headache for most of the next day after the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events sore arm, achy upper body, feverish without fever and headache was recovered on an unknown date in Mar2021. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Asthenia, Chills, Nausea, Night blindness
Clinical narrative: Narrowed vision at bedtime; Achy; Weird dreams; Weak; Chills; A little nauseous; Low grade fever; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 19Apr2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown, if the patient received any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy. The events did not result in doctor or other healthcare professional office or clinic visit or emergency visit. No therapeutic measures were taken as a result of the reported events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy were recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Narrowed vision at bedtime; Achy; Weird dreams; Weak; Chills; A little nauseous; Low grade fever; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 19Apr2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown, if the patient received any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy. The events did not result in doctor or other healthcare professional office or clinic visit or emergency visit. No therapeutic measures were taken as a result of the reported events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events narrowed vision at bedtime, little nauseous, low grade fever, weird dreams, chills, weak and achy were recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypoaesthesia, Pain, Pyrexia, Tremor
Clinical narrative: Next morning woke up with numbness in hands and legs; Severe body chills; Shakes; Whole body hurt and body aches all over; Fever the night of vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 08:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 23:30, the night of vaccine, the patient experienced fever. On 17Apr2021, next morning, the patient woke up with numbness in hands and legs, severe body chills, shakes and whole body hurt and body aches all over. All side effects lasted until the next morning and were all gone at the same time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, numbness in hands and legs, chills, shakes and whole body hurt and body aches all over were resolved on 18Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient . A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 22Apr2021 at 00:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 13:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 00:00, the patient experienced 5 hours of chills, another 8 hours of fever and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills was resolved on 22Apr2021 at 06:00; while that of fever and headache was resolved on 22Apr2021 at 09:00.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Fatigue, Hypoaesthesia, Mobility decreased
Clinical narrative: Experienced numbness; Pain through armpit and shoulder; Pain through armpit; Extreme fatigue for 7 days after injection; Left arm where vaccine was injected was extremely painful/ Pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4; Limited mobility on day 1 and 2.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to red wine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 17Apr2021 at 16:00, the patient experienced extreme pain in  left arm where vaccine was injected was and had limited mobility on day 1 and 2 (17Apr2021-19Apr2021). The patient also experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 (19Apr2021- 20Apr2021) and extreme fatigue for 7 days after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported events which included treatment paracetamol (TYLENOL) and sleep. The clinical outcome of the events extreme fatigue was recovered on 24Apr2021, after the duration of 7 days. The clinical outcome of events left arm where vaccine was injected was extremely painful and had limited mobility on day 1 and 2, experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 and extreme fatigue was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Experienced numbness; Pain through armpit and shoulder; Pain through armpit; Extreme fatigue for 7 days after injection; Left arm where vaccine was injected was extremely painful/ Pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4; Limited mobility on day 1 and 2.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to red wine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 17Apr2021 at 16:00, the patient experienced extreme pain in  left arm where vaccine was injected was and had limited mobility on day 1 and 2 (17Apr2021-19Apr2021). The patient also experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 (19Apr2021- 20Apr2021) and extreme fatigue for 7 days after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported events which included treatment paracetamol (TYLENOL) and sleep. The clinical outcome of the events extreme fatigue was recovered on 24Apr2021, after the duration of 7 days. The clinical outcome of events left arm where vaccine was injected was extremely painful and had limited mobility on day 1 and 2, experienced numbness and pain through armpit and shoulder all the way to ring and pinky fingers on day 3 and 4 and extreme fatigue was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Parosmia, Taste disorder
Clinical narrative: Patient reports feeling symptoms oflow blood sugar the day after thevaccination; strange taste; Strange smell; This is a spontaneous report from a non-contactable pharmacist. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 15Apr2021 at 08:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD). The patient did not have a history of allergies to medications, food, or other products. Concomitant medications included omeprazole (PRILOSEC) from unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced strange taste and smell which started about 24 hours after the vaccine and lasted for about 48 hours. On 16Apr2021, the patient reported feeling symptoms of low blood sugar the day after the vaccination, despite having eaten normally. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strange taste and smell was resolved on 17Apr2021, after the duration of 24 hours (and 48 hours after vaccination). The clinical outcome of the event feeling symptoms of low blood sugar was resolved on an unknown date at Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: Nausea; Stomach pains/. stomach pains have gotten much worse; Major headache; Body aches; Fatigue; Had typical arm sore; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, next morning, the patient experienced typical arm sore then had diarrhea and the patient was good for next 2 days. On 17Apr2021, the patient woke up on Saturday with a major headache then as the day went on body aches and fatigue set in. On 19Apr2021, Monday the patient had started getting stomach pains. On 20Apr2021 (reported as today), the stomach pains had gotten much worse leading to diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the headache which included paracetamol (TYLENOL) every 8 hours to control headache and for other events was not taken. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event typical arm sore was resolved on an unknown date in Apr2021; whereas for the events diarrhea, major headache, body aches, fatigue, stomach pains and nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Nausea; Stomach pains/. stomach pains have gotten much worse; Major headache; Body aches; Fatigue; Had typical arm sore; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, next morning, the patient experienced typical arm sore then had diarrhea and the patient was good for next 2 days. On 17Apr2021, the patient woke up on Saturday with a major headache then as the day went on body aches and fatigue set in. On 19Apr2021, Monday the patient had started getting stomach pains. On 20Apr2021 (reported as today), the stomach pains had gotten much worse leading to diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the headache which included paracetamol (TYLENOL) every 8 hours to control headache and for other events was not taken. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event typical arm sore was resolved on an unknown date in Apr2021; whereas for the events diarrhea, major headache, body aches, fatigue, stomach pains and nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.